Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by Abouttime1on Nov 09, 2021 11:10am
289 Views
Post# 34104860

Email from director

Email from directorCopied from another board: as an early retail investor you will appreciate the success the company has had in one year. Literally out of near bankruptcy to financial stability and most importantly clear recognition of our technology with a Joint Venture with GE Healthcare. This accomplishment has not come without a major strain on our human resources....as many hats are worn by just a few persons. I point this out as you should know this impacts all execution of initiatives in a timely basis. You have asked valid questions which deserve straight answers all owners (shareholders) want . As we are restricted as officers and Directors of the company, what news we share must be done openly and with clarity for all at the same time. As Dr. Adams has stated...news..and lots of it is forthcoming...And the GE initiative is developing strongly ...; we will not be disappointed...; we just cannot talk about it right now. Peter Weichler ,Director
<< Previous
Bullboard Posts
Next >>